Axim Biotech

Axim Biotech is a company listed under the stock ticker AXIM (US).

View the org chart displaying its 11 main executives

Most searched biographies at Axim Biotech

• John Huemoeller, Chief Executive Officer and Director
• Mauricio Gatto-Bellorato, Director
• Timothy Scott, Director

Create your alert
to follow the executive moves at Axim Biotech.

Axim Biotech has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Axim Biotech

Social media about Axim Biotech

• Axim Biotech on Wikipedia, Google News & Yahoo Finance
• Axim Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including John Huemoeller

Call Axim Biotech at +1 84...

View the org chart

Register to receive your alert

Report an error